Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 2937
Selected: 0
NCT IDTitle
NCT00193531Paclitaxel, Carboplatin, and Oral Etoposide Followed by Weekly Paclitaxel in High Grade Neuroendocrine Carcinoma
NCT01404572Taste Assessment Study of 2 Atazanavir Powder Formulations in Healthy Subjects
NCT00732719Compression Device Safety Study on Edema
NCT04227457Prospective Epidemiological Study of Metastatic Non Small Cell Lung Cancer (NSCLC) in Latin America
NCT05939700Mavacamten Pregnancy Surveillance Program
NCT03668119A Study of Nivolumab Combined With Ipilimumab and Nivolumab Alone in Patients With Advanced or Metastatic Solid Tumors of High Tumor Mutational Burden (TMB-H)
NCT02912234Effect of Clarithromycin on the Pharmacokinetics of Apixaban in Healthy Participants
NCT03800602Nivolumab and Metformin in Patients With Treatment Refractory MSS Colorectal Cancer
NCT00000671A Phase II Efficacy Study Comparing 2',3'-Dideoxyinosine (ddI) (BMY-40900) and Zidovudine Therapy of Patients With HIV Infection Who Have Been on Long Term Zidovudine Treatment
NCT02368301Expanded Access Treatment Protocol CA204-143
NCT01092728Treatment With Dasatinib in Patients With Acral Lentiginous, Mucosal, or Chronic Sun-damaged Melanoma
NCT01241292Japanese Study of BMS-901608 (Elotuzumab) in Combination With Lenalidomide and Low Dose Dexamethasone
NCT00046345Atazanavir for HIV Infected Individuals: An Early Access Program
NCT05858645Correction of Psoriatic T Cell Signatures by Deucravacitinib
NCT02108639To Assess the Effect of Renal Impairment on the Blood Levels of Daclatasvir (DCV), Asunaprevir (ASV) and BMS-791325 After Multiple Doses of a Fixed Dose Combination Tablet
NCT05064436A Study to Evaluate the Safety, Tolerability, Kinetics, Biodistribution and Repeatability of 11C-BMS-986196 After Intravenous (IV) Administration in Healthy Participants and After Repeat IV Administration in Participants With Multiple Sclerosis
NCT00858403Dasatinib in Advanced Non-small Cell Lung Cancer (NSCL) With Ex Vivo and In Vivo Assessment of Tumor Target Modulation
NCT06067841A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer
NCT03656627Nivolumab in Patients With Advanced Non-Small Cell Lung Cancer and Pre-existing Autoimmune Disease
NCT06452329A Study to Evaluate Nivolumab in Patients With Unresectable Advanced/Metastatic Gastric Cancer and Gastroesophageal Junction Cancer
NCT07379827Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT)
NCT03521570Intensity-Modulated Radiation Therapy & Nivolumab for Recurrent or Second Primary Head & Neck Squamous Cell Cancer
NCT00002345The Safety and Effectiveness of Megace in HIV-Infected Women
NCT01152372Experimental Study to Validate the Modified Glucose Disposal Test
NCT07091695Real-world Outcomes Among Patients With Melanoma Treated With Neoadjuvant Nivolumab+Relatlimab or Nivolumab+Ipilimumab
NCT06050512Mezigdomide Plus Ixazomib and Dexamethasone for Relapsed and Refractory Multiple Myeloma
NCT02927769A Study of Nivolumab Plus Brentuximab Vedotin in Patients Between 5 and 30 Years Old, With Hodgkin's Lymphoma (cHL), Relapsed or Refractory From First Line Treatment
NCT03335553A Study of Experimental Medication BMS-986235 in Healthy Subjects
NCT00978731Chronic Myelogenous Leukemia or Philadelphia Chromosome Positive Acute Lymphoblastic Leukemic Study
NCT03184870A Study of BMS-813160 in Combination With Chemotherapy or Nivolumab in Participants With Advanced Solid Tumors
NCT00374179CT-322 in Treating Patients With Advanced Solid Tumors and Non-Hodgkin's Lymphoma
NCT00392769Cetuximab in Patients With Progressive or Recurrent Endometrial Cancer
NCT00862823The Bioequivalence of Atripla in an Oral Liquid Formulation Compared With the Tablet Formulation in Healthy Volunteers
NCT02374242Anti-PD 1 Brain Collaboration for Patients With Melanoma Brain Metastases
NCT00364286Therapy of Chronic Lymphocytic Leukemia With Dasatinib (BMS-354825)
NCT02959554Study in Which Therapy is Either Switched to Nivolumab After 3 Months of Treatment or Therapy is Continued With a Tyrosine Kinase Inhibitor in Patients With Metastatic Renal Cell Carcinoma (RCC) and Disease Control
NCT07171983A Study to Evaluate the Safety, Tolerability, and Drug Levels of BMS-986454 in Participants With Rheumatoid Arthritis
NCT03407105A Dose-Escalation Study of MDX-010 Administered Monthly as Immunotherapy in Subjects Infected With Human Immunodeficiency Virus (HIV)
NCT02090556Long-term Experience With Abatacept SC in Routine Clinical Practice
NCT00279760Phase I/II Multiple-Dose LEA29Y vs CTLAG4Ig vs Placebo in Rheumatoid Arthritis
NCT03925246Efficacy of Nivolumab for Recurrent IDH Mutated High-Grade Gliomas
NCT06549608A Retrospective Cohort Study of Mavacamten Patient Support Program in Canada
NCT01928576Phase II Anti-PD1 Epigenetic Therapy Study in NSCLC.
NCT01478048Study of Bortezomib and Dexamethasone With or Without Elotuzumab to Treat Relapsed or Refractory Multiple Myeloma
NCT01802450Dasatinib in Patients With Chronic Myeloid Leukemia in Chronic Phase
NCT03420768A Study of Experimental Medication BMS-986263 in Adults With Advanced Hepatic Fibrosis After Cure of Hepatitis C
NCT02599649Lirilumab and Nivolumab With 5-Azacitidine in Patients With Myelodysplastic Syndromes (MDS)
NCT03425825Treatment Patterns in Advanced Small Cell Lung Cancer (SCLC)
NCT04658147Feasibility and Efficacy of Perioperative Nivolumab With or Without Relatlimab for Patients With Potentially Resectable Hepatocellular Carcinoma (HCC)
NCT00979394Evaluation of Diabetes Care at Austrian GPs